Global Radiopharmaceutical Solutions Supply, Demand and Key Producers, 2026-2032
The global Radiopharmaceutical Solutions market size is expected to reach $ 14442 million by 2032, rising at a market growth of 8.0% CAGR during the forecast period (2026-2032).
Radiopharmaceutical Solutions refer to a comprehensive system encompassing the research, development, production, preparation, distribution, and clinical application of radiopharmaceuticals. This involves combining radioisotopes with specific biomolecules (such as ligands, antibodies, or small molecules) for diagnostic imaging (PET/SPECT) or targeted therapy (RLT/TRT) of diseases.
Gross Margin Level
The gross margin of the radiopharmaceutical solutions industry is typically significantly higher than that of generic drugs, general medical consumables, and most generic formulations. This is because it's not an industry that simply profits from raw material markups; rather, it's a high-barrier-to-entry sector where value is determined by a combination of factors, including radionuclide acquisition, radiolabeling, GMP hot chamber manufacturing, timely delivery, cold chain and radiation safety management, hospital access, and clinical support. Publicly available company data supports this: Lantheus's revenue in Q1 2025 was $373 million, with a gross profit of $238 million, corresponding to a gross margin of approximately 63.8%; Telix disclosed an overall gross margin of 53% for the first half of 2025, while the core Illuccix product maintained a gross margin of 64%. Based on the publicly available performance of these leading companies, the industry's gross profit margin can be roughly understood as follows: Mature diagnostic radiopharmaceuticals and branded PET/SPECT products typically have a margin between 50% and 65%. Companies with strong distribution networks but handling more compounding and third-party sales will have slightly lower margins. Companies producing therapeutic radiopharmaceuticals, therapeutic products, high-barrier platforms for alpha/beta radionuclides, and those with capabilities in rare isotopes can theoretically maintain higher margins, but they also face greater pressure from capacity investment, quality control, and compliance costs.
Industry Drivers
The growth of this industry primarily stems from the continued rise in the global cancer burden. The WHO indicates that there were approximately 20 million new cancer cases globally in 2022, and this number is projected to exceed 35 million by 2050, a 77% increase from 2022. This directly drives the expansion of demand for tumor imaging diagnostics, precision stratification, and targeted radiotherapy. The second core driver is the accelerated commercialization of therapeutic radiopharmaceuticals, with specific data indicating that growth stems from rising cancer and cardiovascular disease prevalence, as well as increased demand for diagnostic and therapeutic radiopharmaceuticals and medical isotopes. The third driver is that therapeutic radiopharmaceuticals are growing faster than diagnostic radiopharmaceuticals; in the same report, the projected growth rate for the therapeutic nuclear medicine sub-segment is higher than that for the diagnostic sub-segment, indicating that the industry is rapidly upgrading from 'image-assisted' to 'precision treatment platform.' Furthermore, the widespread adoption of hybrid imaging technologies such as PET/CT and SPECT/CT, the construction of nuclear medicine departments in hospitals, the expansion of isotope production capacity, and the introduction of new radionuclide platforms are all continuously boosting the industry's prosperity.
This report studies the global Radiopharmaceutical Solutions demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Radiopharmaceutical Solutions, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Radiopharmaceutical Solutions that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Radiopharmaceutical Solutions total market, 2021-2032, (USD Million)
Global Radiopharmaceutical Solutions total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Radiopharmaceutical Solutions total market, key domestic companies, and share, (USD Million)
Global Radiopharmaceutical Solutions revenue by player, revenue and market share 2021-2026, (USD Million)
Global Radiopharmaceutical Solutions total market by Type, CAGR, 2021-2032, (USD Million)
Global Radiopharmaceutical Solutions total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Radiopharmaceutical Solutions market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Curium, Siemens, GE HealthCare, Lantheus, Jubilant Radiopharma, Cardinal Health, Telix Pharmaceuticals, ITM Isotope Technologies Munich, Bracco Imaging, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Radiopharmaceutical Solutions market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Radiopharmaceutical Solutions Market, By Region:
1. How big is the global Radiopharmaceutical Solutions market?
2. What is the demand of the global Radiopharmaceutical Solutions market?
3. What is the year over year growth of the global Radiopharmaceutical Solutions market?
4. What is the total value of the global Radiopharmaceutical Solutions market?
5. Who are the Major Players in the global Radiopharmaceutical Solutions market?
6. What are the growth factors driving the market demand?
Radiopharmaceutical Solutions refer to a comprehensive system encompassing the research, development, production, preparation, distribution, and clinical application of radiopharmaceuticals. This involves combining radioisotopes with specific biomolecules (such as ligands, antibodies, or small molecules) for diagnostic imaging (PET/SPECT) or targeted therapy (RLT/TRT) of diseases.
Gross Margin Level
The gross margin of the radiopharmaceutical solutions industry is typically significantly higher than that of generic drugs, general medical consumables, and most generic formulations. This is because it's not an industry that simply profits from raw material markups; rather, it's a high-barrier-to-entry sector where value is determined by a combination of factors, including radionuclide acquisition, radiolabeling, GMP hot chamber manufacturing, timely delivery, cold chain and radiation safety management, hospital access, and clinical support. Publicly available company data supports this: Lantheus's revenue in Q1 2025 was $373 million, with a gross profit of $238 million, corresponding to a gross margin of approximately 63.8%; Telix disclosed an overall gross margin of 53% for the first half of 2025, while the core Illuccix product maintained a gross margin of 64%. Based on the publicly available performance of these leading companies, the industry's gross profit margin can be roughly understood as follows: Mature diagnostic radiopharmaceuticals and branded PET/SPECT products typically have a margin between 50% and 65%. Companies with strong distribution networks but handling more compounding and third-party sales will have slightly lower margins. Companies producing therapeutic radiopharmaceuticals, therapeutic products, high-barrier platforms for alpha/beta radionuclides, and those with capabilities in rare isotopes can theoretically maintain higher margins, but they also face greater pressure from capacity investment, quality control, and compliance costs.
Industry Drivers
The growth of this industry primarily stems from the continued rise in the global cancer burden. The WHO indicates that there were approximately 20 million new cancer cases globally in 2022, and this number is projected to exceed 35 million by 2050, a 77% increase from 2022. This directly drives the expansion of demand for tumor imaging diagnostics, precision stratification, and targeted radiotherapy. The second core driver is the accelerated commercialization of therapeutic radiopharmaceuticals, with specific data indicating that growth stems from rising cancer and cardiovascular disease prevalence, as well as increased demand for diagnostic and therapeutic radiopharmaceuticals and medical isotopes. The third driver is that therapeutic radiopharmaceuticals are growing faster than diagnostic radiopharmaceuticals; in the same report, the projected growth rate for the therapeutic nuclear medicine sub-segment is higher than that for the diagnostic sub-segment, indicating that the industry is rapidly upgrading from 'image-assisted' to 'precision treatment platform.' Furthermore, the widespread adoption of hybrid imaging technologies such as PET/CT and SPECT/CT, the construction of nuclear medicine departments in hospitals, the expansion of isotope production capacity, and the introduction of new radionuclide platforms are all continuously boosting the industry's prosperity.
This report studies the global Radiopharmaceutical Solutions demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Radiopharmaceutical Solutions, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Radiopharmaceutical Solutions that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Radiopharmaceutical Solutions total market, 2021-2032, (USD Million)
Global Radiopharmaceutical Solutions total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Radiopharmaceutical Solutions total market, key domestic companies, and share, (USD Million)
Global Radiopharmaceutical Solutions revenue by player, revenue and market share 2021-2026, (USD Million)
Global Radiopharmaceutical Solutions total market by Type, CAGR, 2021-2032, (USD Million)
Global Radiopharmaceutical Solutions total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Radiopharmaceutical Solutions market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Curium, Siemens, GE HealthCare, Lantheus, Jubilant Radiopharma, Cardinal Health, Telix Pharmaceuticals, ITM Isotope Technologies Munich, Bracco Imaging, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Radiopharmaceutical Solutions market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Radiopharmaceutical Solutions Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Diagnostic Radiopharmaceuticals
- Therapeutic Radiopharmaceuticals
- Others
- Radiopharmaceuticals that Emit Single Photons
- Radiopharmaceuticals that Emit Positrons
- Radiopharmaceuticals that Emit Beta Particles
- Radiopharmaceuticals that Emit Alpha Particles
- Injectable Solutions
- Oral Solutions
- Granules
- Others
- Hospital
- Specialist Clinic
- Biopharmaceutical Company
- Others
- Novartis
- Curium
- Siemens
- GE HealthCare
- Lantheus
- Jubilant Radiopharma
- Cardinal Health
- Telix Pharmaceuticals
- ITM Isotope Technologies Munich
- Bracco Imaging
- Bayer
- Eli Lilly
- Jubilant Pharma
- Aurobindo Pharma
- Sinotau
- Global Medical Solutions
- SOFIE Biosciences
1. How big is the global Radiopharmaceutical Solutions market?
2. What is the demand of the global Radiopharmaceutical Solutions market?
3. What is the year over year growth of the global Radiopharmaceutical Solutions market?
4. What is the total value of the global Radiopharmaceutical Solutions market?
5. Who are the Major Players in the global Radiopharmaceutical Solutions market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Radiopharmaceutical Solutions Introduction
1.2 World Radiopharmaceutical Solutions Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Radiopharmaceutical Solutions Total Market by Region (by Headquarter Location)
1.3.1 World Radiopharmaceutical Solutions Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Radiopharmaceutical Solutions Revenue (2021-2032)
1.3.3 China Based Company Radiopharmaceutical Solutions Revenue (2021-2032)
1.3.4 Europe Based Company Radiopharmaceutical Solutions Revenue (2021-2032)
1.3.5 Japan Based Company Radiopharmaceutical Solutions Revenue (2021-2032)
1.3.6 South Korea Based Company Radiopharmaceutical Solutions Revenue (2021-2032)
1.3.7 ASEAN Based Company Radiopharmaceutical Solutions Revenue (2021-2032)
1.3.8 India Based Company Radiopharmaceutical Solutions Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Radiopharmaceutical Solutions Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Radiopharmaceutical Solutions Consumption Value (2021-2032)
2.2 World Radiopharmaceutical Solutions Consumption Value by Region
2.2.1 World Radiopharmaceutical Solutions Consumption Value by Region (2021-2026)
2.2.2 World Radiopharmaceutical Solutions Consumption Value Forecast by Region (2027-2032)
2.3 United States Radiopharmaceutical Solutions Consumption Value (2021-2032)
2.4 China Radiopharmaceutical Solutions Consumption Value (2021-2032)
2.5 Europe Radiopharmaceutical Solutions Consumption Value (2021-2032)
2.6 Japan Radiopharmaceutical Solutions Consumption Value (2021-2032)
2.7 South Korea Radiopharmaceutical Solutions Consumption Value (2021-2032)
2.8 ASEAN Radiopharmaceutical Solutions Consumption Value (2021-2032)
2.9 India Radiopharmaceutical Solutions Consumption Value (2021-2032)
3 WORLD RADIOPHARMACEUTICAL SOLUTIONS COMPANIES COMPETITIVE ANALYSIS
3.1 World Radiopharmaceutical Solutions Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Radiopharmaceutical Solutions Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Radiopharmaceutical Solutions in 2025
3.2.3 Global Concentration Ratios (CR8) for Radiopharmaceutical Solutions in 2025
3.3 Radiopharmaceutical Solutions Company Evaluation Quadrant
3.4 Radiopharmaceutical Solutions Market: Overall Company Footprint Analysis
3.4.1 Radiopharmaceutical Solutions Market: Region Footprint
3.4.2 Radiopharmaceutical Solutions Market: Company Product Type Footprint
3.4.3 Radiopharmaceutical Solutions Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Radiopharmaceutical Solutions Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Radiopharmaceutical Solutions Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Radiopharmaceutical Solutions Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Radiopharmaceutical Solutions Consumption Value Comparison
4.2.1 United States VS China: Radiopharmaceutical Solutions Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Radiopharmaceutical Solutions Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Radiopharmaceutical Solutions Companies and Market Share, 2021-2026
4.3.1 United States Based Radiopharmaceutical Solutions Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Radiopharmaceutical Solutions Revenue, (2021-2026)
4.4 China Based Companies Radiopharmaceutical Solutions Revenue and Market Share, 2021-2026
4.4.1 China Based Radiopharmaceutical Solutions Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Radiopharmaceutical Solutions Revenue, (2021-2026)
4.5 Rest of World Based Radiopharmaceutical Solutions Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Radiopharmaceutical Solutions Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Radiopharmaceutical Solutions Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Radiopharmaceutical Solutions Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Diagnostic Radiopharmaceuticals
5.2.2 Therapeutic Radiopharmaceuticals
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Radiopharmaceutical Solutions Market Size by Type (2021-2026)
5.3.2 World Radiopharmaceutical Solutions Market Size by Type (2027-2032)
5.3.3 World Radiopharmaceutical Solutions Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TYPES OF RADIOACTIVE NUCLIDES
6.1 World Radiopharmaceutical Solutions Market Size Overview by Types of Radioactive Nuclides: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Types of Radioactive Nuclides
6.2.1 Radiopharmaceuticals that Emit Single Photons
6.2.2 Radiopharmaceuticals that Emit Positrons
6.2.3 Radiopharmaceuticals that Emit Beta Particles
6.2.4 Radiopharmaceuticals that Emit Alpha Particles
6.3 Market Segment by Types of Radioactive Nuclides
6.3.1 World Radiopharmaceutical Solutions Market Size by Types of Radioactive Nuclides (2021-2026)
6.3.2 World Radiopharmaceutical Solutions Market Size by Types of Radioactive Nuclides (2027-2032)
6.3.3 World Radiopharmaceutical Solutions Market Size Market Share by Types of Radioactive Nuclides (2027-2032)
7 MARKET ANALYSIS BY DOSAGE FORMS
7.1 World Radiopharmaceutical Solutions Market Size Overview by Dosage Forms: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Dosage Forms
7.2.1 Injectable Solutions
7.2.2 Oral Solutions
7.2.3 Granules
7.2.4 Others
7.3 Market Segment by Dosage Forms
7.3.1 World Radiopharmaceutical Solutions Market Size by Dosage Forms (2021-2026)
7.3.2 World Radiopharmaceutical Solutions Market Size by Dosage Forms (2027-2032)
7.3.3 World Radiopharmaceutical Solutions Market Size Market Share by Dosage Forms (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Radiopharmaceutical Solutions Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Specialist Clinic
8.2.3 Biopharmaceutical Company
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Radiopharmaceutical Solutions Market Size by Application (2021-2026)
8.3.2 World Radiopharmaceutical Solutions Market Size by Application (2027-2032)
8.3.3 World Radiopharmaceutical Solutions Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Novartis
9.1.1 Novartis Details
9.1.2 Novartis Major Business
9.1.3 Novartis Radiopharmaceutical Solutions Product and Services
9.1.4 Novartis Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Novartis Recent Developments/Updates
9.1.6 Novartis Competitive Strengths & Weaknesses
9.2 Curium
9.2.1 Curium Details
9.2.2 Curium Major Business
9.2.3 Curium Radiopharmaceutical Solutions Product and Services
9.2.4 Curium Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Curium Recent Developments/Updates
9.2.6 Curium Competitive Strengths & Weaknesses
9.3 Siemens
9.3.1 Siemens Details
9.3.2 Siemens Major Business
9.3.3 Siemens Radiopharmaceutical Solutions Product and Services
9.3.4 Siemens Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Siemens Recent Developments/Updates
9.3.6 Siemens Competitive Strengths & Weaknesses
9.4 GE HealthCare
9.4.1 GE HealthCare Details
9.4.2 GE HealthCare Major Business
9.4.3 GE HealthCare Radiopharmaceutical Solutions Product and Services
9.4.4 GE HealthCare Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 GE HealthCare Recent Developments/Updates
9.4.6 GE HealthCare Competitive Strengths & Weaknesses
9.5 Lantheus
9.5.1 Lantheus Details
9.5.2 Lantheus Major Business
9.5.3 Lantheus Radiopharmaceutical Solutions Product and Services
9.5.4 Lantheus Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Lantheus Recent Developments/Updates
9.5.6 Lantheus Competitive Strengths & Weaknesses
9.6 Jubilant Radiopharma
9.6.1 Jubilant Radiopharma Details
9.6.2 Jubilant Radiopharma Major Business
9.6.3 Jubilant Radiopharma Radiopharmaceutical Solutions Product and Services
9.6.4 Jubilant Radiopharma Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Jubilant Radiopharma Recent Developments/Updates
9.6.6 Jubilant Radiopharma Competitive Strengths & Weaknesses
9.7 Cardinal Health
9.7.1 Cardinal Health Details
9.7.2 Cardinal Health Major Business
9.7.3 Cardinal Health Radiopharmaceutical Solutions Product and Services
9.7.4 Cardinal Health Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Cardinal Health Recent Developments/Updates
9.7.6 Cardinal Health Competitive Strengths & Weaknesses
9.8 Telix Pharmaceuticals
9.8.1 Telix Pharmaceuticals Details
9.8.2 Telix Pharmaceuticals Major Business
9.8.3 Telix Pharmaceuticals Radiopharmaceutical Solutions Product and Services
9.8.4 Telix Pharmaceuticals Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Telix Pharmaceuticals Recent Developments/Updates
9.8.6 Telix Pharmaceuticals Competitive Strengths & Weaknesses
9.9 ITM Isotope Technologies Munich
9.9.1 ITM Isotope Technologies Munich Details
9.9.2 ITM Isotope Technologies Munich Major Business
9.9.3 ITM Isotope Technologies Munich Radiopharmaceutical Solutions Product and Services
9.9.4 ITM Isotope Technologies Munich Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 ITM Isotope Technologies Munich Recent Developments/Updates
9.9.6 ITM Isotope Technologies Munich Competitive Strengths & Weaknesses
9.10 Bracco Imaging
9.10.1 Bracco Imaging Details
9.10.2 Bracco Imaging Major Business
9.10.3 Bracco Imaging Radiopharmaceutical Solutions Product and Services
9.10.4 Bracco Imaging Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Bracco Imaging Recent Developments/Updates
9.10.6 Bracco Imaging Competitive Strengths & Weaknesses
9.11 Bayer
9.11.1 Bayer Details
9.11.2 Bayer Major Business
9.11.3 Bayer Radiopharmaceutical Solutions Product and Services
9.11.4 Bayer Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Bayer Recent Developments/Updates
9.11.6 Bayer Competitive Strengths & Weaknesses
9.12 Eli Lilly
9.12.1 Eli Lilly Details
9.12.2 Eli Lilly Major Business
9.12.3 Eli Lilly Radiopharmaceutical Solutions Product and Services
9.12.4 Eli Lilly Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Eli Lilly Recent Developments/Updates
9.12.6 Eli Lilly Competitive Strengths & Weaknesses
9.13 Jubilant Pharma
9.13.1 Jubilant Pharma Details
9.13.2 Jubilant Pharma Major Business
9.13.3 Jubilant Pharma Radiopharmaceutical Solutions Product and Services
9.13.4 Jubilant Pharma Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Jubilant Pharma Recent Developments/Updates
9.13.6 Jubilant Pharma Competitive Strengths & Weaknesses
9.14 Aurobindo Pharma
9.14.1 Aurobindo Pharma Details
9.14.2 Aurobindo Pharma Major Business
9.14.3 Aurobindo Pharma Radiopharmaceutical Solutions Product and Services
9.14.4 Aurobindo Pharma Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Aurobindo Pharma Recent Developments/Updates
9.14.6 Aurobindo Pharma Competitive Strengths & Weaknesses
9.15 Sinotau
9.15.1 Sinotau Details
9.15.2 Sinotau Major Business
9.15.3 Sinotau Radiopharmaceutical Solutions Product and Services
9.15.4 Sinotau Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Sinotau Recent Developments/Updates
9.15.6 Sinotau Competitive Strengths & Weaknesses
9.16 Global Medical Solutions
9.16.1 Global Medical Solutions Details
9.16.2 Global Medical Solutions Major Business
9.16.3 Global Medical Solutions Radiopharmaceutical Solutions Product and Services
9.16.4 Global Medical Solutions Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Global Medical Solutions Recent Developments/Updates
9.16.6 Global Medical Solutions Competitive Strengths & Weaknesses
9.17 SOFIE Biosciences
9.17.1 SOFIE Biosciences Details
9.17.2 SOFIE Biosciences Major Business
9.17.3 SOFIE Biosciences Radiopharmaceutical Solutions Product and Services
9.17.4 SOFIE Biosciences Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 SOFIE Biosciences Recent Developments/Updates
9.17.6 SOFIE Biosciences Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Radiopharmaceutical Solutions Industry Chain
10.2 Radiopharmaceutical Solutions Upstream Analysis
10.3 Radiopharmaceutical Solutions Midstream Analysis
10.4 Radiopharmaceutical Solutions Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Radiopharmaceutical Solutions Introduction
1.2 World Radiopharmaceutical Solutions Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Radiopharmaceutical Solutions Total Market by Region (by Headquarter Location)
1.3.1 World Radiopharmaceutical Solutions Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Radiopharmaceutical Solutions Revenue (2021-2032)
1.3.3 China Based Company Radiopharmaceutical Solutions Revenue (2021-2032)
1.3.4 Europe Based Company Radiopharmaceutical Solutions Revenue (2021-2032)
1.3.5 Japan Based Company Radiopharmaceutical Solutions Revenue (2021-2032)
1.3.6 South Korea Based Company Radiopharmaceutical Solutions Revenue (2021-2032)
1.3.7 ASEAN Based Company Radiopharmaceutical Solutions Revenue (2021-2032)
1.3.8 India Based Company Radiopharmaceutical Solutions Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Radiopharmaceutical Solutions Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Radiopharmaceutical Solutions Consumption Value (2021-2032)
2.2 World Radiopharmaceutical Solutions Consumption Value by Region
2.2.1 World Radiopharmaceutical Solutions Consumption Value by Region (2021-2026)
2.2.2 World Radiopharmaceutical Solutions Consumption Value Forecast by Region (2027-2032)
2.3 United States Radiopharmaceutical Solutions Consumption Value (2021-2032)
2.4 China Radiopharmaceutical Solutions Consumption Value (2021-2032)
2.5 Europe Radiopharmaceutical Solutions Consumption Value (2021-2032)
2.6 Japan Radiopharmaceutical Solutions Consumption Value (2021-2032)
2.7 South Korea Radiopharmaceutical Solutions Consumption Value (2021-2032)
2.8 ASEAN Radiopharmaceutical Solutions Consumption Value (2021-2032)
2.9 India Radiopharmaceutical Solutions Consumption Value (2021-2032)
3 WORLD RADIOPHARMACEUTICAL SOLUTIONS COMPANIES COMPETITIVE ANALYSIS
3.1 World Radiopharmaceutical Solutions Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Radiopharmaceutical Solutions Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Radiopharmaceutical Solutions in 2025
3.2.3 Global Concentration Ratios (CR8) for Radiopharmaceutical Solutions in 2025
3.3 Radiopharmaceutical Solutions Company Evaluation Quadrant
3.4 Radiopharmaceutical Solutions Market: Overall Company Footprint Analysis
3.4.1 Radiopharmaceutical Solutions Market: Region Footprint
3.4.2 Radiopharmaceutical Solutions Market: Company Product Type Footprint
3.4.3 Radiopharmaceutical Solutions Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Radiopharmaceutical Solutions Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Radiopharmaceutical Solutions Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Radiopharmaceutical Solutions Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Radiopharmaceutical Solutions Consumption Value Comparison
4.2.1 United States VS China: Radiopharmaceutical Solutions Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Radiopharmaceutical Solutions Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Radiopharmaceutical Solutions Companies and Market Share, 2021-2026
4.3.1 United States Based Radiopharmaceutical Solutions Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Radiopharmaceutical Solutions Revenue, (2021-2026)
4.4 China Based Companies Radiopharmaceutical Solutions Revenue and Market Share, 2021-2026
4.4.1 China Based Radiopharmaceutical Solutions Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Radiopharmaceutical Solutions Revenue, (2021-2026)
4.5 Rest of World Based Radiopharmaceutical Solutions Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Radiopharmaceutical Solutions Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Radiopharmaceutical Solutions Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Radiopharmaceutical Solutions Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Diagnostic Radiopharmaceuticals
5.2.2 Therapeutic Radiopharmaceuticals
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Radiopharmaceutical Solutions Market Size by Type (2021-2026)
5.3.2 World Radiopharmaceutical Solutions Market Size by Type (2027-2032)
5.3.3 World Radiopharmaceutical Solutions Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TYPES OF RADIOACTIVE NUCLIDES
6.1 World Radiopharmaceutical Solutions Market Size Overview by Types of Radioactive Nuclides: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Types of Radioactive Nuclides
6.2.1 Radiopharmaceuticals that Emit Single Photons
6.2.2 Radiopharmaceuticals that Emit Positrons
6.2.3 Radiopharmaceuticals that Emit Beta Particles
6.2.4 Radiopharmaceuticals that Emit Alpha Particles
6.3 Market Segment by Types of Radioactive Nuclides
6.3.1 World Radiopharmaceutical Solutions Market Size by Types of Radioactive Nuclides (2021-2026)
6.3.2 World Radiopharmaceutical Solutions Market Size by Types of Radioactive Nuclides (2027-2032)
6.3.3 World Radiopharmaceutical Solutions Market Size Market Share by Types of Radioactive Nuclides (2027-2032)
7 MARKET ANALYSIS BY DOSAGE FORMS
7.1 World Radiopharmaceutical Solutions Market Size Overview by Dosage Forms: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Dosage Forms
7.2.1 Injectable Solutions
7.2.2 Oral Solutions
7.2.3 Granules
7.2.4 Others
7.3 Market Segment by Dosage Forms
7.3.1 World Radiopharmaceutical Solutions Market Size by Dosage Forms (2021-2026)
7.3.2 World Radiopharmaceutical Solutions Market Size by Dosage Forms (2027-2032)
7.3.3 World Radiopharmaceutical Solutions Market Size Market Share by Dosage Forms (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Radiopharmaceutical Solutions Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Specialist Clinic
8.2.3 Biopharmaceutical Company
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Radiopharmaceutical Solutions Market Size by Application (2021-2026)
8.3.2 World Radiopharmaceutical Solutions Market Size by Application (2027-2032)
8.3.3 World Radiopharmaceutical Solutions Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Novartis
9.1.1 Novartis Details
9.1.2 Novartis Major Business
9.1.3 Novartis Radiopharmaceutical Solutions Product and Services
9.1.4 Novartis Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Novartis Recent Developments/Updates
9.1.6 Novartis Competitive Strengths & Weaknesses
9.2 Curium
9.2.1 Curium Details
9.2.2 Curium Major Business
9.2.3 Curium Radiopharmaceutical Solutions Product and Services
9.2.4 Curium Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Curium Recent Developments/Updates
9.2.6 Curium Competitive Strengths & Weaknesses
9.3 Siemens
9.3.1 Siemens Details
9.3.2 Siemens Major Business
9.3.3 Siemens Radiopharmaceutical Solutions Product and Services
9.3.4 Siemens Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Siemens Recent Developments/Updates
9.3.6 Siemens Competitive Strengths & Weaknesses
9.4 GE HealthCare
9.4.1 GE HealthCare Details
9.4.2 GE HealthCare Major Business
9.4.3 GE HealthCare Radiopharmaceutical Solutions Product and Services
9.4.4 GE HealthCare Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 GE HealthCare Recent Developments/Updates
9.4.6 GE HealthCare Competitive Strengths & Weaknesses
9.5 Lantheus
9.5.1 Lantheus Details
9.5.2 Lantheus Major Business
9.5.3 Lantheus Radiopharmaceutical Solutions Product and Services
9.5.4 Lantheus Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Lantheus Recent Developments/Updates
9.5.6 Lantheus Competitive Strengths & Weaknesses
9.6 Jubilant Radiopharma
9.6.1 Jubilant Radiopharma Details
9.6.2 Jubilant Radiopharma Major Business
9.6.3 Jubilant Radiopharma Radiopharmaceutical Solutions Product and Services
9.6.4 Jubilant Radiopharma Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Jubilant Radiopharma Recent Developments/Updates
9.6.6 Jubilant Radiopharma Competitive Strengths & Weaknesses
9.7 Cardinal Health
9.7.1 Cardinal Health Details
9.7.2 Cardinal Health Major Business
9.7.3 Cardinal Health Radiopharmaceutical Solutions Product and Services
9.7.4 Cardinal Health Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Cardinal Health Recent Developments/Updates
9.7.6 Cardinal Health Competitive Strengths & Weaknesses
9.8 Telix Pharmaceuticals
9.8.1 Telix Pharmaceuticals Details
9.8.2 Telix Pharmaceuticals Major Business
9.8.3 Telix Pharmaceuticals Radiopharmaceutical Solutions Product and Services
9.8.4 Telix Pharmaceuticals Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Telix Pharmaceuticals Recent Developments/Updates
9.8.6 Telix Pharmaceuticals Competitive Strengths & Weaknesses
9.9 ITM Isotope Technologies Munich
9.9.1 ITM Isotope Technologies Munich Details
9.9.2 ITM Isotope Technologies Munich Major Business
9.9.3 ITM Isotope Technologies Munich Radiopharmaceutical Solutions Product and Services
9.9.4 ITM Isotope Technologies Munich Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 ITM Isotope Technologies Munich Recent Developments/Updates
9.9.6 ITM Isotope Technologies Munich Competitive Strengths & Weaknesses
9.10 Bracco Imaging
9.10.1 Bracco Imaging Details
9.10.2 Bracco Imaging Major Business
9.10.3 Bracco Imaging Radiopharmaceutical Solutions Product and Services
9.10.4 Bracco Imaging Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Bracco Imaging Recent Developments/Updates
9.10.6 Bracco Imaging Competitive Strengths & Weaknesses
9.11 Bayer
9.11.1 Bayer Details
9.11.2 Bayer Major Business
9.11.3 Bayer Radiopharmaceutical Solutions Product and Services
9.11.4 Bayer Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Bayer Recent Developments/Updates
9.11.6 Bayer Competitive Strengths & Weaknesses
9.12 Eli Lilly
9.12.1 Eli Lilly Details
9.12.2 Eli Lilly Major Business
9.12.3 Eli Lilly Radiopharmaceutical Solutions Product and Services
9.12.4 Eli Lilly Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Eli Lilly Recent Developments/Updates
9.12.6 Eli Lilly Competitive Strengths & Weaknesses
9.13 Jubilant Pharma
9.13.1 Jubilant Pharma Details
9.13.2 Jubilant Pharma Major Business
9.13.3 Jubilant Pharma Radiopharmaceutical Solutions Product and Services
9.13.4 Jubilant Pharma Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Jubilant Pharma Recent Developments/Updates
9.13.6 Jubilant Pharma Competitive Strengths & Weaknesses
9.14 Aurobindo Pharma
9.14.1 Aurobindo Pharma Details
9.14.2 Aurobindo Pharma Major Business
9.14.3 Aurobindo Pharma Radiopharmaceutical Solutions Product and Services
9.14.4 Aurobindo Pharma Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Aurobindo Pharma Recent Developments/Updates
9.14.6 Aurobindo Pharma Competitive Strengths & Weaknesses
9.15 Sinotau
9.15.1 Sinotau Details
9.15.2 Sinotau Major Business
9.15.3 Sinotau Radiopharmaceutical Solutions Product and Services
9.15.4 Sinotau Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Sinotau Recent Developments/Updates
9.15.6 Sinotau Competitive Strengths & Weaknesses
9.16 Global Medical Solutions
9.16.1 Global Medical Solutions Details
9.16.2 Global Medical Solutions Major Business
9.16.3 Global Medical Solutions Radiopharmaceutical Solutions Product and Services
9.16.4 Global Medical Solutions Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Global Medical Solutions Recent Developments/Updates
9.16.6 Global Medical Solutions Competitive Strengths & Weaknesses
9.17 SOFIE Biosciences
9.17.1 SOFIE Biosciences Details
9.17.2 SOFIE Biosciences Major Business
9.17.3 SOFIE Biosciences Radiopharmaceutical Solutions Product and Services
9.17.4 SOFIE Biosciences Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 SOFIE Biosciences Recent Developments/Updates
9.17.6 SOFIE Biosciences Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Radiopharmaceutical Solutions Industry Chain
10.2 Radiopharmaceutical Solutions Upstream Analysis
10.3 Radiopharmaceutical Solutions Midstream Analysis
10.4 Radiopharmaceutical Solutions Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Radiopharmaceutical Solutions Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Radiopharmaceutical Solutions Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Radiopharmaceutical Solutions Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Radiopharmaceutical Solutions Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Radiopharmaceutical Solutions Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Radiopharmaceutical Solutions Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Radiopharmaceutical Solutions Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Radiopharmaceutical Solutions Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Radiopharmaceutical Solutions Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Radiopharmaceutical Solutions Players in 2025
Table 12. World Radiopharmaceutical Solutions Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Radiopharmaceutical Solutions Company Evaluation Quadrant
Table 14. Head Office of Key Radiopharmaceutical Solutions Players
Table 15. Radiopharmaceutical Solutions Market: Company Product Type Footprint
Table 16. Radiopharmaceutical Solutions Market: Company Product Application Footprint
Table 17. Radiopharmaceutical Solutions Mergers & Acquisitions Activity
Table 18. United States VS China Radiopharmaceutical Solutions Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Radiopharmaceutical Solutions Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Radiopharmaceutical Solutions Companies, Headquarters (States, Country)
Table 21. United States Based Companies Radiopharmaceutical Solutions Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Radiopharmaceutical Solutions Revenue Market Share (2021-2026)
Table 23. China Based Radiopharmaceutical Solutions Companies, Headquarters (Province, Country)
Table 24. China Based Companies Radiopharmaceutical Solutions Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Radiopharmaceutical Solutions Revenue Market Share (2021-2026)
Table 26. Rest of World Based Radiopharmaceutical Solutions Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Radiopharmaceutical Solutions Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Radiopharmaceutical Solutions Revenue Market Share (2021-2026)
Table 29. World Radiopharmaceutical Solutions Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Radiopharmaceutical Solutions Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Radiopharmaceutical Solutions Market Size by Type (2027-2032) & (USD Million)
Table 32. World Radiopharmaceutical Solutions Market Size by Types of Radioactive Nuclides, (USD Million), 2021 & 2025 & 2032
Table 33. World Radiopharmaceutical Solutions Market Size Value by Types of Radioactive Nuclides (2021-2026) & (USD Million)
Table 34. World Radiopharmaceutical Solutions Market Size by Types of Radioactive Nuclides (2027-2032) & (USD Million)
Table 35. World Radiopharmaceutical Solutions Market Size by Dosage Forms, (USD Million), 2021 & 2025 & 2032
Table 36. World Radiopharmaceutical Solutions Market Size Value by Dosage Forms (2021-2026) & (USD Million)
Table 37. World Radiopharmaceutical Solutions Market Size by Dosage Forms (2027-2032) & (USD Million)
Table 38. World Radiopharmaceutical Solutions Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Radiopharmaceutical Solutions Market Size by Application (2021-2026) & (USD Million)
Table 40. World Radiopharmaceutical Solutions Market Size by Application (2027-2032) & (USD Million)
Table 41. Novartis Basic Information, Manufacturing Base and Competitors
Table 42. Novartis Major Business
Table 43. Novartis Radiopharmaceutical Solutions Product and Services
Table 44. Novartis Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Novartis Recent Developments/Updates
Table 46. Novartis Competitive Strengths & Weaknesses
Table 47. Curium Basic Information, Manufacturing Base and Competitors
Table 48. Curium Major Business
Table 49. Curium Radiopharmaceutical Solutions Product and Services
Table 50. Curium Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Curium Recent Developments/Updates
Table 52. Curium Competitive Strengths & Weaknesses
Table 53. Siemens Basic Information, Manufacturing Base and Competitors
Table 54. Siemens Major Business
Table 55. Siemens Radiopharmaceutical Solutions Product and Services
Table 56. Siemens Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Siemens Recent Developments/Updates
Table 58. Siemens Competitive Strengths & Weaknesses
Table 59. GE HealthCare Basic Information, Manufacturing Base and Competitors
Table 60. GE HealthCare Major Business
Table 61. GE HealthCare Radiopharmaceutical Solutions Product and Services
Table 62. GE HealthCare Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. GE HealthCare Recent Developments/Updates
Table 64. GE HealthCare Competitive Strengths & Weaknesses
Table 65. Lantheus Basic Information, Manufacturing Base and Competitors
Table 66. Lantheus Major Business
Table 67. Lantheus Radiopharmaceutical Solutions Product and Services
Table 68. Lantheus Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Lantheus Recent Developments/Updates
Table 70. Lantheus Competitive Strengths & Weaknesses
Table 71. Jubilant Radiopharma Basic Information, Manufacturing Base and Competitors
Table 72. Jubilant Radiopharma Major Business
Table 73. Jubilant Radiopharma Radiopharmaceutical Solutions Product and Services
Table 74. Jubilant Radiopharma Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Jubilant Radiopharma Recent Developments/Updates
Table 76. Jubilant Radiopharma Competitive Strengths & Weaknesses
Table 77. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 78. Cardinal Health Major Business
Table 79. Cardinal Health Radiopharmaceutical Solutions Product and Services
Table 80. Cardinal Health Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Cardinal Health Recent Developments/Updates
Table 82. Cardinal Health Competitive Strengths & Weaknesses
Table 83. Telix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 84. Telix Pharmaceuticals Major Business
Table 85. Telix Pharmaceuticals Radiopharmaceutical Solutions Product and Services
Table 86. Telix Pharmaceuticals Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Telix Pharmaceuticals Recent Developments/Updates
Table 88. Telix Pharmaceuticals Competitive Strengths & Weaknesses
Table 89. ITM Isotope Technologies Munich Basic Information, Manufacturing Base and Competitors
Table 90. ITM Isotope Technologies Munich Major Business
Table 91. ITM Isotope Technologies Munich Radiopharmaceutical Solutions Product and Services
Table 92. ITM Isotope Technologies Munich Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. ITM Isotope Technologies Munich Recent Developments/Updates
Table 94. ITM Isotope Technologies Munich Competitive Strengths & Weaknesses
Table 95. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 96. Bracco Imaging Major Business
Table 97. Bracco Imaging Radiopharmaceutical Solutions Product and Services
Table 98. Bracco Imaging Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Bracco Imaging Recent Developments/Updates
Table 100. Bracco Imaging Competitive Strengths & Weaknesses
Table 101. Bayer Basic Information, Manufacturing Base and Competitors
Table 102. Bayer Major Business
Table 103. Bayer Radiopharmaceutical Solutions Product and Services
Table 104. Bayer Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Bayer Recent Developments/Updates
Table 106. Bayer Competitive Strengths & Weaknesses
Table 107. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 108. Eli Lilly Major Business
Table 109. Eli Lilly Radiopharmaceutical Solutions Product and Services
Table 110. Eli Lilly Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Eli Lilly Recent Developments/Updates
Table 112. Eli Lilly Competitive Strengths & Weaknesses
Table 113. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 114. Jubilant Pharma Major Business
Table 115. Jubilant Pharma Radiopharmaceutical Solutions Product and Services
Table 116. Jubilant Pharma Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Jubilant Pharma Recent Developments/Updates
Table 118. Jubilant Pharma Competitive Strengths & Weaknesses
Table 119. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 120. Aurobindo Pharma Major Business
Table 121. Aurobindo Pharma Radiopharmaceutical Solutions Product and Services
Table 122. Aurobindo Pharma Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Aurobindo Pharma Recent Developments/Updates
Table 124. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 125. Sinotau Basic Information, Manufacturing Base and Competitors
Table 126. Sinotau Major Business
Table 127. Sinotau Radiopharmaceutical Solutions Product and Services
Table 128. Sinotau Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Sinotau Recent Developments/Updates
Table 130. Sinotau Competitive Strengths & Weaknesses
Table 131. Global Medical Solutions Basic Information, Manufacturing Base and Competitors
Table 132. Global Medical Solutions Major Business
Table 133. Global Medical Solutions Radiopharmaceutical Solutions Product and Services
Table 134. Global Medical Solutions Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Global Medical Solutions Recent Developments/Updates
Table 136. Global Medical Solutions Competitive Strengths & Weaknesses
Table 137. SOFIE Biosciences Basic Information, Manufacturing Base and Competitors
Table 138. SOFIE Biosciences Major Business
Table 139. SOFIE Biosciences Radiopharmaceutical Solutions Product and Services
Table 140. SOFIE Biosciences Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. SOFIE Biosciences Recent Developments/Updates
Table 142. SOFIE Biosciences Competitive Strengths & Weaknesses
Table 143. Global Key Players of Radiopharmaceutical Solutions Upstream (Raw Materials)
Table 144. Global Radiopharmaceutical Solutions Typical Customers
Table 1. World Radiopharmaceutical Solutions Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Radiopharmaceutical Solutions Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Radiopharmaceutical Solutions Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Radiopharmaceutical Solutions Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Radiopharmaceutical Solutions Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Radiopharmaceutical Solutions Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Radiopharmaceutical Solutions Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Radiopharmaceutical Solutions Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Radiopharmaceutical Solutions Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Radiopharmaceutical Solutions Players in 2025
Table 12. World Radiopharmaceutical Solutions Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Radiopharmaceutical Solutions Company Evaluation Quadrant
Table 14. Head Office of Key Radiopharmaceutical Solutions Players
Table 15. Radiopharmaceutical Solutions Market: Company Product Type Footprint
Table 16. Radiopharmaceutical Solutions Market: Company Product Application Footprint
Table 17. Radiopharmaceutical Solutions Mergers & Acquisitions Activity
Table 18. United States VS China Radiopharmaceutical Solutions Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Radiopharmaceutical Solutions Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Radiopharmaceutical Solutions Companies, Headquarters (States, Country)
Table 21. United States Based Companies Radiopharmaceutical Solutions Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Radiopharmaceutical Solutions Revenue Market Share (2021-2026)
Table 23. China Based Radiopharmaceutical Solutions Companies, Headquarters (Province, Country)
Table 24. China Based Companies Radiopharmaceutical Solutions Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Radiopharmaceutical Solutions Revenue Market Share (2021-2026)
Table 26. Rest of World Based Radiopharmaceutical Solutions Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Radiopharmaceutical Solutions Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Radiopharmaceutical Solutions Revenue Market Share (2021-2026)
Table 29. World Radiopharmaceutical Solutions Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Radiopharmaceutical Solutions Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Radiopharmaceutical Solutions Market Size by Type (2027-2032) & (USD Million)
Table 32. World Radiopharmaceutical Solutions Market Size by Types of Radioactive Nuclides, (USD Million), 2021 & 2025 & 2032
Table 33. World Radiopharmaceutical Solutions Market Size Value by Types of Radioactive Nuclides (2021-2026) & (USD Million)
Table 34. World Radiopharmaceutical Solutions Market Size by Types of Radioactive Nuclides (2027-2032) & (USD Million)
Table 35. World Radiopharmaceutical Solutions Market Size by Dosage Forms, (USD Million), 2021 & 2025 & 2032
Table 36. World Radiopharmaceutical Solutions Market Size Value by Dosage Forms (2021-2026) & (USD Million)
Table 37. World Radiopharmaceutical Solutions Market Size by Dosage Forms (2027-2032) & (USD Million)
Table 38. World Radiopharmaceutical Solutions Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Radiopharmaceutical Solutions Market Size by Application (2021-2026) & (USD Million)
Table 40. World Radiopharmaceutical Solutions Market Size by Application (2027-2032) & (USD Million)
Table 41. Novartis Basic Information, Manufacturing Base and Competitors
Table 42. Novartis Major Business
Table 43. Novartis Radiopharmaceutical Solutions Product and Services
Table 44. Novartis Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Novartis Recent Developments/Updates
Table 46. Novartis Competitive Strengths & Weaknesses
Table 47. Curium Basic Information, Manufacturing Base and Competitors
Table 48. Curium Major Business
Table 49. Curium Radiopharmaceutical Solutions Product and Services
Table 50. Curium Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Curium Recent Developments/Updates
Table 52. Curium Competitive Strengths & Weaknesses
Table 53. Siemens Basic Information, Manufacturing Base and Competitors
Table 54. Siemens Major Business
Table 55. Siemens Radiopharmaceutical Solutions Product and Services
Table 56. Siemens Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Siemens Recent Developments/Updates
Table 58. Siemens Competitive Strengths & Weaknesses
Table 59. GE HealthCare Basic Information, Manufacturing Base and Competitors
Table 60. GE HealthCare Major Business
Table 61. GE HealthCare Radiopharmaceutical Solutions Product and Services
Table 62. GE HealthCare Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. GE HealthCare Recent Developments/Updates
Table 64. GE HealthCare Competitive Strengths & Weaknesses
Table 65. Lantheus Basic Information, Manufacturing Base and Competitors
Table 66. Lantheus Major Business
Table 67. Lantheus Radiopharmaceutical Solutions Product and Services
Table 68. Lantheus Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Lantheus Recent Developments/Updates
Table 70. Lantheus Competitive Strengths & Weaknesses
Table 71. Jubilant Radiopharma Basic Information, Manufacturing Base and Competitors
Table 72. Jubilant Radiopharma Major Business
Table 73. Jubilant Radiopharma Radiopharmaceutical Solutions Product and Services
Table 74. Jubilant Radiopharma Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Jubilant Radiopharma Recent Developments/Updates
Table 76. Jubilant Radiopharma Competitive Strengths & Weaknesses
Table 77. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 78. Cardinal Health Major Business
Table 79. Cardinal Health Radiopharmaceutical Solutions Product and Services
Table 80. Cardinal Health Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Cardinal Health Recent Developments/Updates
Table 82. Cardinal Health Competitive Strengths & Weaknesses
Table 83. Telix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 84. Telix Pharmaceuticals Major Business
Table 85. Telix Pharmaceuticals Radiopharmaceutical Solutions Product and Services
Table 86. Telix Pharmaceuticals Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Telix Pharmaceuticals Recent Developments/Updates
Table 88. Telix Pharmaceuticals Competitive Strengths & Weaknesses
Table 89. ITM Isotope Technologies Munich Basic Information, Manufacturing Base and Competitors
Table 90. ITM Isotope Technologies Munich Major Business
Table 91. ITM Isotope Technologies Munich Radiopharmaceutical Solutions Product and Services
Table 92. ITM Isotope Technologies Munich Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. ITM Isotope Technologies Munich Recent Developments/Updates
Table 94. ITM Isotope Technologies Munich Competitive Strengths & Weaknesses
Table 95. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 96. Bracco Imaging Major Business
Table 97. Bracco Imaging Radiopharmaceutical Solutions Product and Services
Table 98. Bracco Imaging Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Bracco Imaging Recent Developments/Updates
Table 100. Bracco Imaging Competitive Strengths & Weaknesses
Table 101. Bayer Basic Information, Manufacturing Base and Competitors
Table 102. Bayer Major Business
Table 103. Bayer Radiopharmaceutical Solutions Product and Services
Table 104. Bayer Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Bayer Recent Developments/Updates
Table 106. Bayer Competitive Strengths & Weaknesses
Table 107. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 108. Eli Lilly Major Business
Table 109. Eli Lilly Radiopharmaceutical Solutions Product and Services
Table 110. Eli Lilly Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Eli Lilly Recent Developments/Updates
Table 112. Eli Lilly Competitive Strengths & Weaknesses
Table 113. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 114. Jubilant Pharma Major Business
Table 115. Jubilant Pharma Radiopharmaceutical Solutions Product and Services
Table 116. Jubilant Pharma Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Jubilant Pharma Recent Developments/Updates
Table 118. Jubilant Pharma Competitive Strengths & Weaknesses
Table 119. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 120. Aurobindo Pharma Major Business
Table 121. Aurobindo Pharma Radiopharmaceutical Solutions Product and Services
Table 122. Aurobindo Pharma Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Aurobindo Pharma Recent Developments/Updates
Table 124. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 125. Sinotau Basic Information, Manufacturing Base and Competitors
Table 126. Sinotau Major Business
Table 127. Sinotau Radiopharmaceutical Solutions Product and Services
Table 128. Sinotau Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Sinotau Recent Developments/Updates
Table 130. Sinotau Competitive Strengths & Weaknesses
Table 131. Global Medical Solutions Basic Information, Manufacturing Base and Competitors
Table 132. Global Medical Solutions Major Business
Table 133. Global Medical Solutions Radiopharmaceutical Solutions Product and Services
Table 134. Global Medical Solutions Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Global Medical Solutions Recent Developments/Updates
Table 136. Global Medical Solutions Competitive Strengths & Weaknesses
Table 137. SOFIE Biosciences Basic Information, Manufacturing Base and Competitors
Table 138. SOFIE Biosciences Major Business
Table 139. SOFIE Biosciences Radiopharmaceutical Solutions Product and Services
Table 140. SOFIE Biosciences Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. SOFIE Biosciences Recent Developments/Updates
Table 142. SOFIE Biosciences Competitive Strengths & Weaknesses
Table 143. Global Key Players of Radiopharmaceutical Solutions Upstream (Raw Materials)
Table 144. Global Radiopharmaceutical Solutions Typical Customers
LIST OF FIGURES
Figure 1. Radiopharmaceutical Solutions Picture
Figure 2. World Radiopharmaceutical Solutions Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Radiopharmaceutical Solutions Total Revenue (2021-2032) & (USD Million)
Figure 4. World Radiopharmaceutical Solutions Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Radiopharmaceutical Solutions Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Radiopharmaceutical Solutions Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Radiopharmaceutical Solutions Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Radiopharmaceutical Solutions Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Radiopharmaceutical Solutions Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Radiopharmaceutical Solutions Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Radiopharmaceutical Solutions Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Radiopharmaceutical Solutions Revenue (2021-2032) & (USD Million)
Figure 13. Radiopharmaceutical Solutions Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Radiopharmaceutical Solutions Consumption Value (2021-2032) & (USD Million)
Figure 16. World Radiopharmaceutical Solutions Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Radiopharmaceutical Solutions Consumption Value (2021-2032) & (USD Million)
Figure 18. China Radiopharmaceutical Solutions Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Radiopharmaceutical Solutions Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Radiopharmaceutical Solutions Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Radiopharmaceutical Solutions Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Radiopharmaceutical Solutions Consumption Value (2021-2032) & (USD Million)
Figure 23. India Radiopharmaceutical Solutions Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Radiopharmaceutical Solutions by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Radiopharmaceutical Solutions Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Radiopharmaceutical Solutions Markets in 2025
Figure 27. United States VS China: Radiopharmaceutical Solutions Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Radiopharmaceutical Solutions Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Radiopharmaceutical Solutions Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Radiopharmaceutical Solutions Market Size Market Share by Type in 2025
Figure 31. Diagnostic Radiopharmaceuticals
Figure 32. Therapeutic Radiopharmaceuticals
Figure 33. Others
Figure 34. World Radiopharmaceutical Solutions Market Size Market Share by Type (2021-2032)
Figure 35. World Radiopharmaceutical Solutions Market Size by Types of Radioactive Nuclides, (USD Million), 2021 & 2025 & 2032
Figure 36. World Radiopharmaceutical Solutions Market Size Market Share by Types of Radioactive Nuclides in 2025
Figure 37. Radiopharmaceuticals that Emit Single Photons
Figure 38. Radiopharmaceuticals that Emit Positrons
Figure 39. Radiopharmaceuticals that Emit Beta Particles
Figure 40. Radiopharmaceuticals that Emit Alpha Particles
Figure 41. World Radiopharmaceutical Solutions Market Size Market Share by Types of Radioactive Nuclides (2021-2032)
Figure 42. World Radiopharmaceutical Solutions Market Size by Dosage Forms, (USD Million), 2021 & 2025 & 2032
Figure 43. World Radiopharmaceutical Solutions Market Size Market Share by Dosage Forms in 2025
Figure 44. Injectable Solutions
Figure 45. Oral Solutions
Figure 46. Granules
Figure 47. Others
Figure 48. World Radiopharmaceutical Solutions Market Size Market Share by Dosage Forms (2021-2032)
Figure 49. World Radiopharmaceutical Solutions Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 50. World Radiopharmaceutical Solutions Market Size Market Share by Application in 2025
Figure 51. Hospital
Figure 52. Specialist Clinic
Figure 53. Biopharmaceutical Company
Figure 54. Others
Figure 55. World Radiopharmaceutical Solutions Market Size Market Share by Application (2021-2032)
Figure 56. Radiopharmaceutical Solutions Industrial Chain
Figure 57. Methodology
Figure 58. Research Process and Data Source
Figure 1. Radiopharmaceutical Solutions Picture
Figure 2. World Radiopharmaceutical Solutions Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Radiopharmaceutical Solutions Total Revenue (2021-2032) & (USD Million)
Figure 4. World Radiopharmaceutical Solutions Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Radiopharmaceutical Solutions Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Radiopharmaceutical Solutions Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Radiopharmaceutical Solutions Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Radiopharmaceutical Solutions Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Radiopharmaceutical Solutions Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Radiopharmaceutical Solutions Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Radiopharmaceutical Solutions Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Radiopharmaceutical Solutions Revenue (2021-2032) & (USD Million)
Figure 13. Radiopharmaceutical Solutions Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Radiopharmaceutical Solutions Consumption Value (2021-2032) & (USD Million)
Figure 16. World Radiopharmaceutical Solutions Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Radiopharmaceutical Solutions Consumption Value (2021-2032) & (USD Million)
Figure 18. China Radiopharmaceutical Solutions Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Radiopharmaceutical Solutions Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Radiopharmaceutical Solutions Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Radiopharmaceutical Solutions Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Radiopharmaceutical Solutions Consumption Value (2021-2032) & (USD Million)
Figure 23. India Radiopharmaceutical Solutions Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Radiopharmaceutical Solutions by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Radiopharmaceutical Solutions Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Radiopharmaceutical Solutions Markets in 2025
Figure 27. United States VS China: Radiopharmaceutical Solutions Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Radiopharmaceutical Solutions Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Radiopharmaceutical Solutions Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Radiopharmaceutical Solutions Market Size Market Share by Type in 2025
Figure 31. Diagnostic Radiopharmaceuticals
Figure 32. Therapeutic Radiopharmaceuticals
Figure 33. Others
Figure 34. World Radiopharmaceutical Solutions Market Size Market Share by Type (2021-2032)
Figure 35. World Radiopharmaceutical Solutions Market Size by Types of Radioactive Nuclides, (USD Million), 2021 & 2025 & 2032
Figure 36. World Radiopharmaceutical Solutions Market Size Market Share by Types of Radioactive Nuclides in 2025
Figure 37. Radiopharmaceuticals that Emit Single Photons
Figure 38. Radiopharmaceuticals that Emit Positrons
Figure 39. Radiopharmaceuticals that Emit Beta Particles
Figure 40. Radiopharmaceuticals that Emit Alpha Particles
Figure 41. World Radiopharmaceutical Solutions Market Size Market Share by Types of Radioactive Nuclides (2021-2032)
Figure 42. World Radiopharmaceutical Solutions Market Size by Dosage Forms, (USD Million), 2021 & 2025 & 2032
Figure 43. World Radiopharmaceutical Solutions Market Size Market Share by Dosage Forms in 2025
Figure 44. Injectable Solutions
Figure 45. Oral Solutions
Figure 46. Granules
Figure 47. Others
Figure 48. World Radiopharmaceutical Solutions Market Size Market Share by Dosage Forms (2021-2032)
Figure 49. World Radiopharmaceutical Solutions Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 50. World Radiopharmaceutical Solutions Market Size Market Share by Application in 2025
Figure 51. Hospital
Figure 52. Specialist Clinic
Figure 53. Biopharmaceutical Company
Figure 54. Others
Figure 55. World Radiopharmaceutical Solutions Market Size Market Share by Application (2021-2032)
Figure 56. Radiopharmaceutical Solutions Industrial Chain
Figure 57. Methodology
Figure 58. Research Process and Data Source
